Pre-selected class-level testing of longitudinal biomarkers reduces required multiple testing corrections to yield novel insights in longitudinal small sample human studies
Statistical Communications in Infectious Diseases · 2020
DOI: 10.1515/scid-2019-0018 ↗Kurz gefasst
Fachartikel in der Zeitschrift Statistical Communications in Infectious Diseases, 2020. Verfasst von Andrea S Foulkes und 2 weiteren Autor:innen. Beteiligte Einrichtung: Biostatistics Center, Massachusetts General Hospital, Boston, USA. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NIGMS NIH HHS, NIDDK NIH HHS.
Abstract (Originalsprache)
Objectives
Exploratory studies that aim to evaluate novel therapeutic strategies in human cohorts often involve the collection of hundreds of variables measured over time on a small sample of individuals. Stringent error control for testing hypotheses in this setting renders it difficult to identify statistically signification associations. The objective of this study is to demonstrate how leveraging prior information about the biological relationships among variables can increase power for novel discovery.
Methods
We apply the class level association score statistic for longitudinal data (CLASS-LD) as an analysis strategy that complements single variable tests. An example is presented that aims to evaluate the relationships among 14 T-cell and monocyte activation variables measured with CD4 T-cell count over three time points after antiretroviral therapy (n=62).
Results
CLASS-LD using three classes with emphasis on T-cell activation with either classical vs. intermediate/inflammatory monocyte subsets detected associations in two of three classes, while single variable testing detected only one out of the 14 variables considered.
Conclusions
Application of a class-level testing strategy provides an alternative to single immune variables by defining hypotheses based on a collection of variables that share a known underlying biological relationship. Broader use of class-level analysis is expected to increase the available information that can be derived from limited sample clinical studies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Biostatistics Center, Massachusetts General Hospital, Boston, USA.
- Department of Medicine, Harvard Medical School, Boston, USA.
- Wistar Institute, Philadelphia, USA.
Förderung
- NIAID NIH HHS
- NIGMS NIH HHS
- NIDDK NIH HHS
- National Institutes of Health
- National Institute of Diabetes and Digestive and Kidney Diseases
- National Institute of General Medical Sciences
- National Institute of Allergy and Infectious Diseases
Zitieren
APA
Foulkes, A. S., Azzoni, L., & Montaner, L. J. (2020). Pre-selected class-level testing of longitudinal biomarkers reduces required multiple testing corrections to yield novel insights in longitudinal small sample human studies. Statistical Communications in Infectious Diseases. https://doi.org/10.1515/scid-2019-0018
Vancouver
Foulkes AS, Azzoni L, Montaner LJ. Pre-selected class-level testing of longitudinal biomarkers reduces required multiple testing corrections to yield novel insights in longitudinal small sample human studies. Statistical Communications in Infectious Diseases. 2020. doi:10.1515/scid-2019-0018
BibTeX
@article{Foulkes2020,
author = {Foulkes, Andrea S and Azzoni, Livio and Montaner, Luis J},
title = {Pre-selected class-level testing of longitudinal biomarkers reduces required multiple testing corrections to yield novel insights in longitudinal small sample human studies},
journal = {Statistical Communications in Infectious Diseases},
year = {2020},
doi = {10.1515/scid-2019-0018}
}
EUVIMED